You are here

Article info

Article menu

Download PDFPDF

Case report
Restless legs syndrome following the use of ziprasidone: a case report

Authors

  • Cuizhen Zhu Department of Sleeping Disorder, Anhui Mental Health Center, Hefei, Anhui, ChinaDepartment of Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China PubMed articlesGoogle scholar articles
  • Ran Bi Department of Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaSchool of Public Health, Schulich School of Medicine and Dentistry, London, Ontario, Canada PubMed articlesGoogle scholar articles
  • Yuliang Hu Department of Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Psychiatry and Psychology, Mayo Clinic School of Graduate Medical Education, Rochester, Minnesota, USA PubMed articlesGoogle scholar articles
  • Hui Zhou Department of Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaShanghai Mental Health Center, Shanghai, China PubMed articlesGoogle scholar articles
  • Daomin Zhu Department of Sleeping Disorder, Anhui Mental Health Center, Hefei, Anhui, China PubMed articlesGoogle scholar articles
  • Brian Isaacson Psychiatry Department, AtlantiCare Regional Medical Center, Atlantic City, New Jersey, USA PubMed articlesGoogle scholar articles
  • Qingwei Li Department of Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China PubMed articlesGoogle scholar articles
  • Yezhe Lin Department of Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Psychiatry, University of Rochester Medical Center, Rochester, New York, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Yezhe Lin; yezhe.lin{at}foxmail.com
View Full Text

Citation

Zhu C, Bi R, Hu Y, et al
Restless legs syndrome following the use of ziprasidone: a case report
General Psychiatry 2020;33:e100112. doi: 10.1136/gpsych-2019-100112

Publication history

  • Received July 11, 2019
  • Revision received October 7, 2019
  • Accepted November 28, 2019
  • First published March 11, 2020.
Online issue publication 
May 15, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.